Abstract Objective: Both first-(FGAs) and second-generation antipsychotics (SGAs) are
routinely used in treating severe and persistent psychiatric disorders. However, until now no …

Psychiatric conditions (including substance misuse disorders) are serious, potentially life
threatening illnesses that can be successfully treated by psychotropic drugs, even during …

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge
for clinicians and women with mental health problems, owing to the uncertainties around …

These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) published guidelines
for the management of bipolar disorder in 2005, with a 2007 update. This second update, in …

Objective To investigate the risks of adverse pregnancy and birth outcomes for treated and
untreated bipolar disorder during pregnancy. Design Population based cohort study using …

Background and methods: Little is understood about why few women during the perinatal
period will use depression treatment. In particular, beliefs and barriers related to depression …

The effect of various antipsychotics during pregnancy has repeatedly been studied, but for
most atypical antipsychotics, only little information is available. We identified from the …

Women of childbearing age are often affected with psychotic disorders, requiring the use of
antipsychotic medication during pregnancy. In the present study, we prospectively followed …

Background Drug safety has the highest priority in the treatment of pregnant women, as any
effect on fetal development will not be immediately evident, and the harm that ensues may …